Amundi USD High Yield Corporate Bond ESG UCITS ETF (BUN8)

Of course all your hypothetical situations would result in huge runs. 

I made bank off enzc. Unfortunately a very different market today .

It's all good.......Nilsen's(co-founder & CEO) background aligns closely with the company's core technology: biophysics, electrophysiology, bioelectric stimulation systems, government research programs, patents, and multiple exits. That kind of profile often becomes especially valuable when a compan

12,34,77,97

Good Luck Everyone!!

NFLX cpps 77.38 / 78.12 (2/24/26) Gap filled

https://www.stockscores.com/chart.asp?TickerSymbol=NFLX&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=None&ChartWidth=950&ChartHeight=300&LogScale=None&Band=&avgType1=SMA&movAvg1=20&avgType2=SMA&movAvg2=5&Indicator1=No

Such a shame.

https://www.wfmz.com/health/man-s-numbness-on-right-side-of-body-was-sign-of-deadly-brain-tumor/article_7f9009cf-1c76-5354-970a-16554781fc9d.html

Why is it every time good news comes out on this stock 2 things happen: it will go up that day, and then the next day it trends down for the next few days???????

Nothing wrong with putting out hypothetical situations

Go to LinkedIn.. search VitOrgan.. you will find a lot of profiles working for them, many mention Biomolecular in their profiles. You have to get translations from German to English .. which is what I did.

T cell therapy still only impressive in B cell blood cancers. Why, because T cell therapy is used to target self in the body that our immune systems avoid attacking. B cells are not necessary to survive if completely removed from our systems temporarily.

Genetically modified dendrit

I’d take that 100,000% run all day every day lol. 

Can’t get in to this right now, if I don’t have something concrete to stare at. 

Isn’t this from 2018 ? Maybe this explains the problem with the PPS

Look I agree with all that we should be worth more. That said , we’re not. That’s why we hold CEO’s accountable for stock performance. For creating shareholder value. Nasrat has overseen a 50 percent drop

AMZN, buy the dip
https://investorshub.advfn.com/uimage/uploads/2026/6/21/jbwszIMG_2249.png

https://people.com/dad-thought-dizziness-was-from-quitting-drinking-alcohol-turned-out-to-be-brain-tumor-12001899

🤷‍♀️

Elite is doing well with the exception of the PPS. That’s all I care about. Nothing else. 82 cents to 36 cents is unacceptable. Especially for such a so called great company. So , great results but crappy PPS. That’s on Nasrat as he doesn’t manage the PPS. He doesn’t seem to care.

Any updates from Danish’s House? Is that band playing? All you can eat pancakes?

My target is to own 1000 Sol's and put them into a self-custody crypto wallet for a long term investment. I think Sol has a tremendous potential to grow big...

Yes, the NWS was certainly illegal. That being said, in my opinion, the terms of the conservatorship are a major Takings violation. Who gives a loan that when paid off the lender owns 95% of the collateral for the loan? The warrants alone represent 80% of the outstanding stock. Who besides the gover

BEST SELLERS RANK (BSR) IS 356 45 Estimated Sold on Amazon Since APRIL 1 - 2ND Quarter 2026
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value D

Rules for thee and not for me - that is what is going on with the Trumper family AND CONgress.

I'll watch the Tom Lee video in a while - gotta head out on some errands.

I am looking forward to what is hopefully good news from the federal/provincial govt. by the end of

REDUCE-IT CKM: In REDUCE-IT secondary prevention patients, the CKM syndrome was associated with incremental CVD risk compared with MetS without diabetes and normal renal function. IPE treatment further reduced CVD risk in patients with CKM, thereby supporting a role for this therapy in affected pati

Conductor TOOHOT checking in—thanks for your patience during the brief pause.
The BIEL Train Bound for Glory resumes boarding this Monday.
Entry prices remain low—for now.
All aboard to those joining the ride. 🚂
$BIEL




BUY $BI

Here's the interview. Frank G. is one of my favorites.

https://www.youtube.com/watch?v=bNuljOP4Ric

Don't forget the 58 amazing scientists signing away their reputation on the peer reviewed paper and the entire Scientific Advisory Board that must have been implicit too.

The alternative is simply a poorly run biotech with a drug that may not work well enough to gain approval and a bu

Of course I agree with you ... there's no way IQM Quantum is not familiar with Perkinamine and who knows to what extent they're using it.

Dr. Ciesla is joing an apparently impressive team at IQM, which has four co-founders according to its website:

https://iqm.tech/pres